Abstract: Process for reducing the extent of Cryptosporidium diarrhoeas, which comprises administering to a patient in need thereof a therapeutically effective amount of yeasts of the Saccharomyces boulardii species. The yeasts are freeze-dried living yeasts. The yeasts are provided in the form of unit doses containing 0.050 to 3.0 g of yeasts.
Abstract: A method for treating epilepsy in humans which comprises administering stiripentol to a patient under antiepileptic treatment with usual drugs in order to alleviate or prevent side effects. The invention also provides an antiepileptic composition comprising stiripentol.
Type:
Grant
Filed:
March 1, 1991
Date of Patent:
March 10, 1992
Assignee:
Laboratoires Biocodex
Inventors:
Rene H. Levy, Joan S. Lockard, Richard H. Finnell, Bernard M. Hublot, Jacques A. Tor
Abstract: A method for the treatment of amoebiasis in humans, comprising administering to a human patient suffering from amoebiasis a therapeutically effective amount of yeasts of the genus Saccharomyces. The yeasts are preferably lyophilized, and are administered at a daily dosage level of 0.5-10 g. The species Saccharomyces boulardii is preferred.
Abstract: The invention relates to a method for preventing or treating pseudo-membranous colitis in a patient submitted to antibiotic treatment by means of Saccharomyces yeasts.
© 2024 Justia
